Annual General Meeting 2018
The Annual General Meeting was held on May 29, 2018, in Marseille, France.
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a clinical-stage biotechnology company with a focus on discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients
Headlines
AACR 2018
Innate Pharma presented new data at the AACR Annual Meeting, April 14-18, in Chicago, including preliminary data suggesting promising anti-tumor activity of the combination of monalizumab and cetuximab in patients with platinum pretreated SCCHN.
2017 financial statements
Innate Pharma releases its 2017 financial statements on March 8, 2018.
Latest news
Outcome of Annual General Meeting of May 29, 2018
May 29, 2018
Upcoming events
European Congress of Immunology 2018 (ECI 2018) | Amsterdam, Netherlands
September 2, 2018 to September 4, 2018
ESMO 2018 Congress | Munich, Germany
October 19, 2018 to October 23, 2018
SITC Annual Meeting 2018 | Washington DC, USA
November 7, 2018 to November 11, 2018